You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

cetuximab

Showing 26 - 50 of 558
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Squamous Cell Carcinoma of the Head and Neck Trial in Le Havre (Pembrolizumab, Cetuximab, Radiotherapy)

Active, not recruiting
  • Squamous Cell Carcinoma of the Head and Neck
  • Le Havre, France
    Centre Guillaume le conquérant
Aug 18, 2022

Squamous Cell Carcinoma of the Oropharynx, Squamous Cell Carcinoma of the Larynx, Squamous Cell Carcinoma of the Oral Cavity

Active, not recruiting
Has Results
  • Squamous Cell Carcinoma of the Oropharynx
  • +7 more
  • Tampa, Florida
  • +2 more
Dec 30, 2022

HPV-unrelated Head and Neck Squamous Cell Carcinoma Trial in Saint Louis (Palbociclib, Cetuximab)

Recruiting
  • HPV-unrelated Head and Neck Squamous Cell Carcinoma
  • Saint Louis, Missouri
    Washington University School of Medicine
Apr 7, 2022

BRAF NP_004324.2:p.V600X, KRAS wt Allele, Metastatic Malignant Solid Tumor Trial in Houston (biological, drug, other)

Active, not recruiting
  • BRAF NP_004324.2:p.V600X
  • +6 more
  • Cetuximab
  • +4 more
  • Houston, Texas
    M D Anderson Cancer Center
Sep 22, 2022

Microsatellite Stable Metastatic Colorectal Cancer Trial in Tucson, Aurora, New Brunswick (ALX148, Cetuximab, Pembrolizumab)

Recruiting
  • Microsatellite Stable Metastatic Colorectal Cancer
  • Tucson, Arizona
  • +2 more
Jul 28, 2022

Colorectal Cancer Trial in Hangzhou (Ametumumab, Anti-PD-1 mAb, Cetuximab)

Not yet recruiting
  • Colorectal Cancer
  • Hangzhou, Zhejiang, China
    Sir Run Run Shaw Hospital, Zhejiang University School of Medicin
Jan 30, 2023

Head Neck Cancer, Squamous Cell Carcinoma of the Head and Neck Trial in La Jolla (Ibrutinib 560mg PO daily (Imbruvica),

Active, not recruiting
  • Head and Neck Cancer
  • Squamous Cell Carcinoma of the Head and Neck
  • Ibrutinib 560mg PO daily (Imbruvica)
  • +2 more
  • La Jolla, California
    UCSD Moores Cancer Center
Jan 11, 2023

HNSCC Trial in Lorient (Cetuximab, avelumab, Cisplatin)

Active, not recruiting
  • HNSCC
  • Cetuximab
  • +3 more
  • Lorient, France
    Centre Hospitalier Bretagne Sud
Mar 10, 2022

Squamous Cell Carcinoma of Head and Neck Trial in Aurora (sEphB4-HSA with chemo, Cetuximab, Radiation Therapy)

Completed
  • Squamous Cell Carcinoma of Head and Neck
  • sEphB4-HSA with chemotherapy
  • +2 more
  • Aurora, Colorado
    University of Colorado Hospital
Dec 9, 2022

Colorectal Cancer Trial in Salt Lake City (Cetuximab)

Recruiting
  • Colorectal Cancer
  • Cetuximab
  • Salt Lake City, Utah
  • +1 more
May 3, 2022

Head Neck Cancer, Squamous Cell Carcinoma Trial in London (Avelumab, Cetuximab)

Active, not recruiting
  • Head and Neck Cancer
  • Squamous Cell Carcinoma
  • London, United Kingdom
    University College Hospital
May 17, 2022

Head and Neck Squamous Cell Cancer, Recurrent Head and Neck Squamous Cell Cancer, Metastatic Head and Neck Squamous Cell Cancer

Active, not recruiting
  • Head and Neck Squamous Cell Cancer
  • +2 more
  • Miami, Florida
  • +8 more
Dec 2, 2022

Colon Cancer, Resected Stage Trial in Houston (Cetuximab, CB-NK-TGF-βR2-/NR3C1, Fludarabine phosphate)

Recruiting
  • Colon Cancer
  • Resected Stage
  • Cetuximab
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Jul 23, 2022

Treatment Related Cancer Trial in Munich (5-FU, Folinic Acid, Irinotecan)

Active, not recruiting
  • Treatment Related Cancer
  • Munich, Germany
    Ludwig Maximilians University
Jan 19, 2022

Head and Neck Squamous Cell Carcinoma Trial in La Jolla (Avelumab, Palbociclib, Cetuximab)

Active, not recruiting
  • Head and Neck Squamous Cell Carcinoma
  • La Jolla, California
    UC San Diego Moores Cancer Center
Feb 16, 2022

Metastatic Colorectal Cancer Trial in Italy (Cetuximab, Avelumab)

Recruiting
  • Metastatic Colorectal Cancer
  • Ancona, Italy
  • +23 more
Oct 25, 2022

Head and Neck Squamous Cell Carcinoma, Cutaneous Squamous Cell Carcinoma, Head Neck Cancer Trial in United States (Lenvatinib

Completed
  • Head and Neck Squamous Cell Carcinoma
  • +3 more
  • Lenvatinib Pill
  • Cetuximab
  • Basking Ridge, New Jersey
  • +6 more
Oct 13, 2022

BRAF V600E, Metastatic Colorectal Cancer Trial in China (Encorafenib, Cetuximab, FOLFIRI)

Recruiting
  • BRAF V600E
  • Metastatic Colorectal Cancer
  • Beijing, Beijing, China
  • +33 more
Dec 20, 2022

Carcinoma, Squamous Cell of Head and Neck Trial in Darmstadt (Cetuximab, Cisplatin/Carboplatin, 5-fluorouracil)

Completed
Has Results
  • Carcinoma, Squamous Cell of Head and Neck
  • Cetuximab
  • +2 more
  • Darmstadt, Germany
    Research site
Apr 19, 2022

Colorectal Tumors Trial in Philadelphia (bevacizumab, cetuximab, Oxaliplatin)

Terminated
Has Results
  • Colorectal Neoplasms
  • Philadelphia, Pennsylvania
    Fox Chase Cancer Center
Dec 30, 2021

Squamous Cell Carcinoma of the Head and Neck Trial in Pittsburgh (Cetuximab, Stereotactic radiosurgery)

Completed
Has Results
  • Squamous Cell Carcinoma of the Head and Neck
  • Cetuximab
  • Stereotactic radiosurgery
  • Pittsburgh, Pennsylvania
    University of Pittsburgh Cancer Institute
Feb 10, 2022

Cancer of the Colon, Colon Cancer, Colon Tumors Trial in Chapel Hill (Cetuximab, Palbociclib)

Recruiting
  • Cancer of the Colon
  • +4 more
  • Chapel Hill, North Carolina
    Lineberger Comprehensive Cancer Center at University of North Ca
Jan 25, 2022

Metastatic Colorectal Cancer Trial in Munich (Irinotecan, Folinic Acid, 5-FU)

Recruiting
  • Metastatic Colorectal Cancer
  • Munich, Germany
    Klinikum der Universitaet Muenchen - Campus Grosshadern
Dec 2, 2021

Colorectal Cancer, Colorectal Adenocarcinoma, Colorectal Cancer Metastatic Trial in Chicago (VS-6766, Cetuximab, Pill Diary)

Not yet recruiting
  • Colorectal Cancer
  • +4 more
  • Chicago, Illinois
    University of Chicago Medical Center
Jan 6, 2022

Metastatic Colorectal Cancer Trial in Munich (Bevacizumab, Irinotecan, Folinic acid)

Active, not recruiting
  • Metastatic Colorectal Cancer
  • Munich, Germany
    Klinikum der Universitaet Muenchen
Dec 2, 2021